The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

Johnson & Johnson has priced its new Spravato nasal spray for treatment-resistant depression ... arrived at much the same conclusions. J&J’s Janssen unit – which markets Spravato – said ...

You may not even realize that your steroid nasal spray is causing side effects, as many of them can mimic those of allergies and sinusitis. That’s especially true if you have just started using nasal ...

The nasal spray had to go through many rounds of clinical testing, with some shown to improve depression, while others showed no improvement over a placebo. In 2019, the FDA approved Spravato for ...

This condition occurs when the nasal passages become dependent on the spray to remain open, leading to a vicious cycle of usage and worsening symptoms. Frequent and prolonged use of decongestants can ...

Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing Outpatient Behavioral Health Services is offering a new treatment. The treatment ...

They may discuss switching to a different treatment besides Lamictal or Spravato. Your doctor can give you more information. Is it safe to use a nasal corticosteroid or decongestant during ...